In acute myeloid leukemia (AML), E-selectin helps to retain tumor stem cells within a bone marrow vascular niche which protects these cells from the effect of cytotoxic chemotherapeutics (Barbier et al., 2020). This evidence concerns the gene SELE and acute myeloid leukemia.